title: Exogenous administration of Substance P enhances wound healing in a novel skin-injury model.
abstract: Soft tissue injury accounts for approximately 44% of all wounds in both the military and civilian populations. Following injury to soft tissue, Substance P (SP) and other neuropeptides are released by cutaneous neurons and modulate the function of immunocompetent and inflammatory cells, as well as epithelial and endothelial cells. The interaction between these components of the nervous system and multiple target cells affecting cutaneous repair is of increasing interest. In this report, we describe the effects of SP on wound repair in a novel, laser-induced, skin-wound model. Gross and histologic examination of laser-induced injury revealed that exogenously administered SP affects wound healing via neurite outgrowth, in addition to adhesion molecule and neurokinin-1 receptor involvement in vivo. All SP effects were decreased by pretreatment with Spantide II, an SP antagonist. The elucidation of SP-mediating mechanisms is crucial to firmly establishing the involvement and interaction of the peripheral nervous system and the immune system in cutaneous repair. Findings presented here suggest that SP participates in the complex network of mediators involved in cutaneous inflammation and wound healing.
authors.affiliation: Combat Casualty Care Branch, U.S. Army Institute of Surgical Research, Fort Sam Houston, Texas 78234, USA.
authors.forename: Angel V
authors.initials: AV
authors.lastname: Delgado
authors.forename: Albert T
authors.initials: AT
authors.lastname: McManus
authors.forename: James P
authors.initials: JP
authors.lastname: Chambers
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D039081:Integrin alpha5beta1 / Q000187:drug effects; D018799:Intercellular Adhesion Molecule-1 / Q000187:drug effects; D007834:Lasers; D008297:Male; D016501:Neurites / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018040:Receptors, Neurokinin-1 / Q000187:drug effects; D012867:Skin / Q000473:pathology*; D012879:Skin Physiological Phenomena; D013373:Substance P / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D039081:Integrin alpha5beta1; D018040:Receptors, Neurokinin-1; D018799:Intercellular Adhesion Molecule-1; C065446:spantide II; D013373:Substance P